Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price traded down 3.8% during trading on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. 384,329 shares were traded during mid-day trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8 %
The company has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The business’s fifty day simple moving average is C$0.26 and its two-hundred day simple moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- Which Wall Street Analysts are the Most Accurate?
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Insider Trading – What You Need to Know
- Progress Software Stock Back in the Green After Beating Forecasts
- Stock Average Calculator
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
